Document Classification

Section Type: RESULTS

Text: The cumulative prevalence of eczema by 4 years (Hazard ratio (HR) 0. 57 (95 % CI 0. 39-0. 83)) and prevalence of rhinoconjunctivitis at 4 years (Relative risk 0. 38 (95 % CI 0. 18-0. 83)) were significantly reduced in the children taking HN001 ; there were also nonsignificant reductions in the cumulative prevalence of SCORAD 10 (HR 0. 74 (95 % CI 0. 52-1. 05), wheeze (HR 0. 79 (95 % CI 0. 59-1. 07)) and atopic sensitization (HR = 0. 72 (95 % CI 0. 48-1. 06)).